You have 9 free searches left this month | for more free features.

folfirinox

Showing 1 - 25 of 46

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pancreatic Ductal Adenocarcinoma Trial (OT-101, FOLFIRINOX)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • (no location specified)
Oct 5, 2023

Pancreatic Ductal Adenocarcinoma Trial in Houston (Pembrolizumab, Folfirinox)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Houston, Texas
  • +1 more
Dec 15, 2022

Pancreas Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in Boston (drug, radiation, procedure)

Recruiting
  • Pancreas Cancer
  • +2 more
  • FOLFIRINOX
  • +9 more
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Aug 19, 2022

Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma Trial in Washington (Eryaspase,

Active, not recruiting
  • Locally Advanced Pancreatic Ductal Adenocarcinoma
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Eryaspase
  • FOLFIRINOX
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Aug 3, 2022

Metastatic Pancreatic Cancer Trial in Philadelphia (FOLFIRINOX)

Recruiting
  • Metastatic Pancreatic Cancer
  • FOLFIRINOX
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Sep 26, 2022

Pancreatic Cancer Trial in United States (drug, radiation, procedure)

Active, not recruiting
  • Pancreatic Cancer
  • FOLFIRINOX
  • +4 more
  • Aurora, Colorado
  • +9 more
Sep 7, 2022

ADjuvant chemotherAPy After Curative Intent resecTion of

Recruiting
  • Ampullary Adenocarcinoma
  • Brescia, BS, Italy
    Fondazione Poliambulanza
Oct 3, 2023

Metastatic Pancreatic Ductal Adenocarcinoma Trial in France, Spain (CAN04, FOLFIRINOX)

Recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Bordeaux, France
  • +7 more
May 16, 2022

Pancreatic Cancer Trial in Baltimore (drug, biological, radiation)

Active, not recruiting
  • Pancreatic Cancer
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 3, 2022

Gastroesophageal Adenocarcinoma Trial in Orange (device, combination product, drug)

Not yet recruiting
  • Gastroesophageal Adenocarcinoma
  • ctDNA Blood Test
  • +8 more
  • Orange, California
    Chao Family Comprehensive Cancer Center, University
Feb 8, 2023

Pancreatic Cancer Trial in Boston (drug, radiation, procedure)

Active, not recruiting
  • Pancreatic Cancer
  • FOLFIRINOX
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital
May 5, 2021

Pancreas Cancer Trial in Cincinnati (drug, radiation, procedure)

Recruiting
  • Pancreas Cancer
  • Folfirinox
  • +3 more
  • Tucson, Arizona
  • +1 more
Sep 13, 2022

Pancreatic Cancer Trial in New York (Biopsy, FOLFIRINOX, Ciprofloxacin)

Not yet recruiting
  • Pancreatic Cancer
  • Biopsy
  • +5 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jul 13, 2022

Pancreas Cancer Trial in Louisville (Irreversible Electroporation (IRE), Gemcitabine, FOLFIRINOX)

Recruiting
  • Pancreas Cancer
  • Irreversible Electroporation (IRE)
  • +2 more
  • Louisville, Kentucky
    University of Louisville
Oct 6, 2021

Metastatic Pancreatic Cancer Trial in France (FOLFIRINOX, LV5FU2, FOLFIRI.3)

Completed
  • Metastatic Pancreatic Cancer
  • FOLFIRINOX
  • +3 more
  • Angers, France
  • +53 more
Dec 3, 2021

Colorectal Tumors Trial in São Paulo (Folfirinox)

Recruiting
  • Colorectal Neoplasms
  • Folfirinox
  • São Paulo, Brazil
    Hospital Municipal Vila Santa Catarina
Oct 5, 2021

Gastric Cancer Trial in São Paulo (FOLFIRINOX)

Recruiting
  • Gastric Cancer
  • FOLFIRINOX
  • São Paulo, Brazil
    Instituto do Câncer do Estado de São Paulo
Nov 9, 2020

Pancreatic Adenocarcinoma Trial in Providence (FOLFIRI, FOLFIRINOX, TriSalus Infusion System)

Withdrawn
  • Pancreatic Adenocarcinoma
  • Providence, Rhode Island
    Roger Williams Medical Center
May 27, 2021

Urachal Cancer Trial in Seoul (FOLFIRINOX)

Recruiting
  • Urachal Cancer
  • FOLFIRINOX
  • Seoul, Korea, Republic of
    Asan Medical Center
Oct 29, 2020

Borderline Resectable Pancreatic Cancer Trial (FOLFIRINOX, gemcitabine + nab-paclitaxel)

Active, not recruiting
  • Borderline Resectable Pancreatic Cancer
  • FOLFIRINOX
  • gemcitabine + nab-paclitaxel
  • (no location specified)
Sep 8, 2020

Pancreatic Cancer Trial in Boston (FOLFIRINOX, Losartan, Proton Beam Radiation)

Unknown status
  • Pancreatic Cancer
  • FOLFIRINOX
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 7, 2020

Metastatic Pancreatic Adenocarcinoma Trial in Montpellier (GEMBRAX, FOLFIRINOX)

Completed
  • Metastatic Pancreatic Adenocarcinoma
  • Montpellier, France
    Institut regional du Cancer - Val d Aurelle
Dec 30, 2020

Locally Advanced and Metastatic Pancreatic Cancer Trial in Shanghai (PD-L1/CTLA4 BsAb, GP, FOLFIRINOX)

Recruiting
  • Locally Advanced and Metastatic Pancreatic Cancer
  • PD-L1/CTLA4 BsAb
  • +2 more
  • Shanghai, Shanghai, China
    Changhai hospital
Aug 3, 2021

Metastatic Pancreas Cancer Trial in Amsterdam (Folfirinox)

Recruiting
  • Metastatic Pancreas Cancer
  • Folfirinox
  • Amsterdam, Noord-Holland, Netherlands
    Academic Medical Center
May 18, 2021